InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2026-03-03 | Gilbert Cisneros(D-CA31) | house | Purchase | $1,001 - $15,000 |
| 2026-01-15 | Gilbert Cisneros(D-CA31) | house | Purchase | $1,001 - $15,000 |
| 2026-01-05 | Gilbert Cisneros(D-CA31) | house | Purchase | $1,001 - $15,000 |
No financial data available for LGND.
Company may not file with SEC or CIK is unresolved.
Villere St Denis Dumps 134,000 Tidewater (TDW) Shares Worth $9.3 Million
LGND: XOMA Buy Adds 100+ Assets
Ligand Pharmaceuticals And 2 Other Stocks That May Be Trading At An Estimated Discount
XOMA Royalty (XOMA) Moves 10.7% Higher: Will This Strength Last?
Ligand Pharmaceuticals to Buy XOMA Royalty for $39/Share, Lifts 2026 Guidance and EPS Outlook
Royalty Powerhouse: Ligand And Xoma Unite In $739 Million Deal
Ligand Pharmaceuticals Incorporated (LGND) XOMA Royalty Corporation - M&A Call - Slideshow
Ligand Pharmaceuticals Incorporated (LGND) M&A Call Transcript
Ligand Pharmaceuticals buying Xoma Royalty for $739 million
Ligand to buy XOMA Royalty for $39/share
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
Ligand Pharmaceuticals to buy XOMA Royalty in $740M all-cash deal: WSJ